Click Column title to sort
- Print Version of Table (pdf) | download Adobe Acrobat Reader (free)
- Components Page
- Excipients Table
| Excipient | Purpose | Vaccine Name | Vaccine Type | Amount per 0.5 mL Dose |
|---|---|---|---|---|
| Acetic Acid | Adjust pH | Spikevax (Moderna) | COVID-19 | 0.043 mg |
| Albumin, Bovine | Stabilizer | Vaqta | HepA | <10–4 mcg |
| Albumin, Bovine | Stabilizer | Zostavax | Varicella Zoster | Trace amounts |
| Albumin, Bovine Serum | Stabilizer | Pediarix | DTaP+HepB+IPV | VERO cell culture growth |
| Albumin, Bovine Serum | Stabilizer | Kinrix | DTaP+IPV | VERO cell culture growth |
| Albumin, Bovine Serum | Stabilizer | Quadracel | DTaP+IPV | ≤50 ng |
| Albumin, Bovine Serum | Stabilizer | Vaxelis | DTaP+IPV+HepB | ≤50 ng |
| Albumin, Bovine Serum | Stabilizer | Pentacel | DTaP+IPV+Hib | ≤50 ng |
| Albumin, Bovine Serum | Stabilizer | Prehevbrio | HepB | <2.5 ng/mL |
| Albumin, Bovine Serum | Stabilizer | Ixiaro | Japanese Encephalitis | ≤100 ng/mL |
| Albumin, Bovine Serum | Stabilizer | MMR-II | MMR | <1 ppm |
| Albumin, Bovine serum | Stabilizer | Priorix | MMR | ≤50 mcg |
| Albumin, Bovine Serum | Stabilizer | RabAvert | Rabies | “Small quantities’, US origin |
| Albumin, Bovine Serum | Stabilizer | RotaTeq | Rotavirus | Trace amounts |
| Albumin, Bovine Serum | Stabilizer | Varivax | Varicella | Trace amounts |
| Albumin, Calf Serum Protein | Stabilizer | IPOL | IPV | <50 ng |
| Albumin, Egg (Ovalbumin) | Residual Medium | Afluria Quad | Influenza | ≤1 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | Fluad Quad | Influenza | ≤1.5 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | Fluarix Quad | Influenza | ≤0.05 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | Flulaval Quad | Influenza | ≤0.3 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | FluMist Quad | Influenza | ≤0.024 mcg/0.2mL dose |
| Albumin, Egg (Ovalbumin) | Residual Medium | Fluvirin | Influenza | ≤1 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | Priorix | MMR | ≤60 mcg |
| Albumin, Egg (Ovalbumin) | Residual Medium | RabAvert | Rabies | ≤3 ng/1 mL dose |
| Amphotericin B | Antimicrobial | RabAvert | Rabies | ≤20 ng/1 mL dose |
| Chlortetracycline | Antimicrobial | RabAvert | Rabies | ≤200 ng/1 mL dose |
| Egg Protein | Residual Medium | Fluad | Influenza | <0.4 mcg |
| Gelatin | Manufacturing Residue | JE-Vax | Japanese Encephalitis | 500 mcg/1 mL dose |
| Gelatin | Gelatin Capsules | Vivotif | Typhoid | Gelatin Capsule |
| Gelatin | Manufacturing Residue | YF-Vax | Yellow Fever | Amount not specified in package insert |
| Gelatin, Bovine | Stabilizer, solvent | RabAvert | Rabies | ≤12 mg/1 mL dose polygeline |
| Gelatin, hydrolyzed | Stabilizer | MMR-II | MMR | 14.5 mg |
| Gelatin, hydrolyzed | Stabilizer | ProQuad | MMRV | 11 mg |
| Gelatin, hydrolyzed | Stabilizer | Varivax | Varicella | 12.5 mg |
| Gelatin, Porcine, Hydrolyzed | Stabilizer | FluMist Quad | Influenza | 2.00 mg/0.2 mL dose |
| Gelatin, Porcine, Hydrolyzed | Stabilizer | Zostavax | Varicella Zoster | 15.58 mg/0.65 mL dose |
| Gentamicin | Antimicrobial | Jynneos | Smallpox and Monkeypox | ≤ 0.163 mcg |
| Gentamicin Sulfate | Antimicrobial | Fluarix Quad | Influenza | ≤0.15 mcg |
| Gentamicin Sulfate | Antimicrobial | FluMist Quad | Influenza | <0.015 mcg/mL |
| Latex | Pharmaceutical closure | Boostrix | Tdap | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Engerix-B | HepB | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Fluvirin | Influenza | Tip caps of prefilled syringes may contain natural rubber latex |
| Latex | Pharmaceutical closure | Havrix | HepA | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Infanrix | DTaP | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Kinrix | DTaP+IPV | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Pediarix | DTaP+HepB+IPV | Tip caps of prefilled syringes contain natural rubber latex |
| Latex | Pharmaceutical closure | Rotarix | Rotavirus | Tip caps of prefilled oral applicators contain natural rubber latex |
| Latex | Pharmaceutical closure | Tenivac | Td | Tip caps of prefilled syringes may contain natural rubber latex |
| Latex | Pharmaceutical closure | Twinrix | HepA+HepB | Tip caps of the prefilled syringes contain natural rubber latex |
| Neomycin | Antimicrobial | Fluad | Influenza | ≤0.02 mcg |
| Neomycin | Antimicrobial | Fluad Quad | Influenza | ≤0.02 mcg |
| Neomycin | Antimicrobial | Fluvirin | Influenza | ≤2.5 mcg |
| Neomycin | Antimicrobial | IPOL | IPV | <5 ng |
| Neomycin | Antimicrobial | Kinrix | DTaP+IPV | ≤0.05 ng |
| Neomycin | Antimicrobial | MMR-II | MMR | 25 mcg |
| Neomycin | Antimicrobial | Pediarix | DTaP+HepB+IPV | ≤0.05 ng |
| Neomycin | Antimicrobial | Pentacel | DTaP+IPV+Hib | <4 pg |
| Neomycin | Antimicrobial | ProQuad | MMRV | <16 mcg |
| Neomycin | Antimicrobial | Quadracel | DTaP+IPV | <4 pg |
| Neomycin | Antimicrobial | RabAvert | Rabies | <10 mcg/1 mL dose |
| Neomycin | Antimicrobial | Vaqta | HepA | <10 ppb (residual) |
| Neomycin | Antimicrobial | Varivax | Varicella | Trace amounts |
| Neomycin | Antimicrobial | Vaxelis | DTaP+IPV+HepB | <5 ng |
| Neomycin | Antimicrobial | Zostavax | Varicella Zoster | Trace amounts |
| Neomycin Sulfate | Antimicrobial | Afluria Quad | Influenza | ≤81.8 ng |
| Neomycin Sulfate | Antimicrobial | Havrix | HepA | ≤40 ng/mL |
| Neomycin Sulfate | Antimicrobial | Imovax | Rabies | <150 mcg/mL |
| Neomycin Sulfate | Antimicrobial | Priorix | MMR | ≤25 mcg |
| Neomycin Sulfate | Antimicrobial | Twinrix | HepA+HepB | ≤20 ng/mL |
| Polyethylene Glycol[1] | Lipid | Comirnaty (Pfizer) | COVID-19 | 0.05 mg 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide/0.3 mL dose |
| Polyethylene Glycol* | Lipid | Spikevax (Moderna) | COVID-19 | 1.93 mg (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG] |
| Polymyxin | Antimicrobial | Fluvirin | Influenza | ≤3.75 mcg |
| Polymyxin B | Antimicrobial | Afluria Quad | Influenza | ≤14 ng |
| Polymyxin B | Antimicrobial | IPOL | Polio | 25 ng |
| Polymyxin B | Antimicrobial | Kinrix | DTaP+IPV | ≤0.01 ng |
| Polymyxin B | Antimicrobial | Pediarix | DTaP+HepB+IPV | ≤0.01 ng |
| Polymyxin B | Antimicrobial | Pentacel | DTaP+IPV+Hib | <4 pg |
| Polymyxin B Sulfate | Antimicrobial | Quadracel | DTaP+IPV | <4 pg |
| Polymyxin B Sulfate | Antimicrobial | Vaxelis | DTaP+IPV+HepB | <25 ng |
| Polysorbate 20* | Surfactant | Flublok Quad | Influenza | ≤27.5 mcg (Tween 20) |
| Polysorbate 20* | Surfactant | Havrix | HepA | 0.05 mg/mL |
| Polysorbate 20* | Surfactant | Twinrix | HepA+HepB | Amount not specified in package insert |
| Polysorbate 20* | Surfactant | Vaxneuvance | Pneumococcal 15 | 1 mg |
| Polysorbate 80* | Surfactant | Boostrix | Tdap | ≤100 mcg (Tween 80) |
| Polysorbate 80* | Surfactant | COVID-19 vaccine by Janssen* | COVID-19 | 0.16 mg |
| Polysorbate 80* | Surfactant | Fluad | Influenza | 1.175 mg |
| Polysorbate 80* | Surfactant | Fluad Quad | Influenza | ≤1500 1.175 mcg |
| Polysorbate 80* | Surfactant | Fluarix Quad | Influenza | ≤0.550 mg (Tween 80) |
| Polysorbate 80* | Surfactant | Flucelvax Quad | Influenza | ≤1500 mcg (Tween 80) |
| Polysorbate 80* | Surfactant | Flulaval Quad | Influenza | ≤887 mcg |
| Polysorbate 80* | Surfactant | Gardasil | HPV | 50 mcg |
| Polysorbate 80* | Surfactant | Gardasil 9 | HPV | 50 mcg |
| Polysorbate 80* | Surfactant | Heplisav-B | HepB | 0.1 mg/mL |
| Polysorbate 80* | Surfactant | Infanrix | DTaP | ≤100 mcg (Tween 80) |
| Polysorbate 80* | Surfactant | JE-Vax | Japanese Encephalitis | <0.0007% |
| Polysorbate 80* | Surfactant | Kinrix | DTaP+IPV | ≤100 mcg (Tween 80) |
| Polysorbate 80* | Surfactant | Pediarix | DTaP+HepB+IPV | ≤100 mcg (Tween 80) |
| Polysorbate 80* | Surfactant | Pentacel | DTaP+IPV+Hib | 10 ppm |
| Polysorbate 80* | Surfactant | Prevnar 13 | Pneumococcal 13-valent | 100 mcg |
| Polysorbate 80* | Surfactant | Prevnar 20 | Pneumococcal 20-valent | 100 mcg |
| Polysorbate 80* | Surfactant | Quadracel | DTaP+IPV | 10 ppm |
| Polysorbate 80* | Surfactant | RotaTeq | Rotavirus | Amount not specified in package insert |
| Polysorbate 80* | Surfactant | Shingrix | Zoster | 0.08 mg |
| Polysorbate 80* | Surfactant | Trumenba | Meningococcal Group B | 0.018 mg |
| Polysorbate 80* | Surfactant | Vaxelis | DTaP+IPV+HepB | <0.0056% |
| Sodium Taurodeoxycholate | Protein Purifier | Afluria Quad | Influenza | ≤10 ppm (residual) |
| Streptomycin | Antimicrobial | IPOL | Polio | 200 ng |
| Streptomycin sulfate | Manufacturing Residue | Vaxelis | DTaP+IPV+HepB | <200 ng |
| Thimerosal | Preservative | Afluria Quad | Influenza | 24.5 mcg mercury only in multi-dose vial; none in single dose |
| Thimerosal | Preservative | Flucelvax Quad | Influenza | <25 mcg mercury only in multi-dose vial; none in single dose |
| Thimerosal | Preservative | Fluvirin | Influenza | 25 mcg mercury/dose in multi-dose vial; ≤1 mcg/dose mercury in prefilled syringe |
| Thimerosal | Preservative | FluZone Quad | Influenza | 25 mcg mercury in multi-dose vial; none in single dose |
| Thimerosal | Preservative | JE-Vax | Japanese Encephalitis | 0.007% |
| Thimerosal | Preservative | Menomune | Meningococcal | 25 mcg mercury/dose in multi-dose diluent; none in single dose |
| Thimerosal | Manufacturing Residue | TDVax | Tetanus+Diphtheria | ≤0.3 mcg mercury (trace amounts) |
| Yeast | Medium Nutrient | Engerix-B | HepB | ≤5% yeast protein |
| Yeast | Medium Nutrient | Gardasil | HPV | <7 mcg yeast protein |
| Yeast | Medium Nutrient | Gardasil 9 | HPV | <7 mcg yeast protein |
| Yeast | Medium Nutrient | Heplisav-B | HepB | Yeast protein: residual amounts (≤5.0% of total protein) Yeast DNA: <20 pg |
| Yeast | Medium Nutrient | Menveo | Meningococcal | Amount not specified in package insert |
| Yeast | Medium Nutrient | Pediarix | DTaP+HepB+IPV | ≤5% yeast protein |
| Yeast | Medium Nutrient | Prevnar 13 | Pneumococcal 13-valent | Ingredient in growth medium |
| Yeast | Medium Nutrient | Prevnar 20 | Pneumococcal 20-valent | Ingredient in growth medium |
| Yeast | Medium Nutrient | Recombivax HB | HepB | <1% yeast protein |
| Yeast | Medium Nutrient | Twinrix | HepA+HepB | ≤5% yeast protein |
| Yeast | Medium Nutrient | Vaxelis | DTaP+IPV+HepB | ≤0.1 mcg |
| Yeast | Medium Nutrient | Vaxneuvance | Pneumococcal 15 | Amount not specified in package insert |
| Yeast | Medium Nutrient | Vivotif | Typhoid | Amount not specified in package insert |
[1] This product is not FDA-approved but was authorized for use under the Emergency Use Authorization on February 27, 2021.
| This information is correct to the best of our knowledge. Any inaccuracies should be reported to us at info@hopkinsvaccine.org |
